Winston Churchill once said that success is not the final ending, that failure is by far from being fatal and that if you have courage, you will be able to move forward in whatever you do. The words of Winston Churchill are a secret to those of the Jewish community for over 5000 years.
No matter what life throws at you, the good and the bad, you must have courage to get over your fears. It is more than just triumph that keeps the Jewish community moving forward. It is also the courage they have to be faced with the hate against their religion and they must carry the strength to continue moving forward to have traditions be kept by the Jewish religion.
Through the years, the increase in hate has spiked to an alarming high. The rise of antisemitism is causing strain on the Jewish community. Not only in Israel but also in the United States. The rise of hatred comes from years of hate that can not be easily transformed. It will take years beyond years to break the cycle of hate towards Jews.
In an effort to help bring awareness to the Jewish religion, Adam Milstein and wife are actively staying involved with countless organizations and foundations which help to promote the values that the Jews have lived by from the beginning.
There is an increase in the amount of campaigns aimed at bringing down the State of Israel and with just as much hope and faith, Adam Milstein is working to bring awareness to the religion. Even if the State of Israel is demolished, Adam Milstein will work equally as hard to maintain the beliefs, values and morals of the Israeli people.
Adam Milstein has experienced life in Israel personally. He has helped to maintain the peace with his help during the Yom Kippur war. He spent his childhood in Israel and they lived by the Jewish code. After becoming an adult and meeting his wife Gila, they decided it was time to further Adam’s education. For this reason, they moved to the United States where Adam returned to school and became involved in real estate investments.
If you know anything about religion, you know that it offers different beliefs based on the teachings of the religion. Christian beliefs and Judaism is both on the tree of religion, with the teachings of Jesus behind the religion. The teachings of Jesus who was a Jew that lived in Israel is what the religion is based on.
If there is anything that we have learned over time, it is that there has always been conflict and prejudice in all religions. No matter what belief you follow, there is always going to be persecution and tragedy in the end. After you know the stories and the beliefs of your religion, the easier it will be for you to stand behind it.
For many, many centuries, there has been rejection to the Jews. The Jewish community is suffering from the persecution and to help make it easier on the younger generation, the help of many organizations is being used to educate those who may have not known about their heritage otherwise.
Adam Milstein is someone who has lived in Israel and knows about the land. The beliefs and values of the Jewish people is better off with different organizations and foundations behind them. Learning about their history and ancestry will help to keep the values moving on generation by generation.
Adam Milstein who is a native to Israel and who has worked to stand behind the beliefs of the Jewish religion, he helps to bring the values and morals of the religion to others in the Jewish community. It has never been easy for those who come from the religion and living life by it can be difficult if you feel alone. Adam Milstein and his wife Gila are hoping to change that.
The Adam Milstein and Gila Family Founation is working to help others live by the values behind their religion. For a religion that has suffered tragically over time, it can be hard to know what is right when there is so much controversy behind it. Adam Milstein hopes that one day the religion can be something more to be known as rather than just tragic and persecution.
Follow Adam: @Facebook.com/adammilsteiniac/
Ricardo Tosto is the most prominent Brazilian Lawyer. Ricardo Tosto stands to be the owner of Leite, Tosto e Barros Advogados. He is a highly experienced business lawyer who has tremendous experience in contracts, commercial, banking, business criminal laws, debt and credit restructuring nas well as many other areas inclusive of credit recovery. Ricardo Tosto holds credible experience in these departments. He has served in several companies such as GrupoRede which is based in Brazil. He used to serve as the Human Resource as well as the legal management team. Ricardo Tosto is also the director of the most prominent director for FundacaoRede de PrevidenciaPrivada. Ricardo is on the record of the most dedicated lawyer in Brazil. He his law firm has proved him as the best lawyer of all times.
Ricardo Tosto has also been awarded. He stands to be the award winner due to his contribution to the law department. Ricardo Tosto was nominated by Who’s Who and was awarded and recognized as one of the leading lawyers in Brazil in the field of commercial litigation. Ricardo Tosto handled this field perfectly well in the representation as well as guiding and advising his clients. The status of his law firm has managed to rise perfectly well and successfully. Ricardo Tosto is a highly respected scholar with several records of accomplishments. His tremendous practice has been perceived by Legal 500 in conjunction with the Brazilian Legal Publication. Click here watch video.
Ricardo Tosto is known to be a self-made Brazilian lawyer who pursued law at Mackenzie University. In addition to this, he holds an extension in Business Administration. Ricardo Tosto also served on the Judicial Reform Committee as well as the Judicial Modernization Committee. Ricardo Tosto is also recognized for his commitment and dedication as a member of the International Bar association (IBA). He is a member of the Study Centre for Attorney Partnership (CESA). Ricardo Tosto is also a co-founder of the prominent IBEDEP. He has managed to handle these boards in a tremendous manner and he has maintained his track of achievement in various aspects of the law.
Dr. Clay Siegall is the Chief Executive Officer, Chairman of the board, the President and the founder of Seattle Genetics. The firm specializes in the development of the therapy drugs that are applied to various types of diseases that have not shown any mortality improvement in decades. Dr. Clay is an accomplished scientist who has undergone training in cancer therapies. The idea of Dr. Clay building the Seattle Genetics was tied to the scientific innovation, passion for helping patients and the rigorous research in science and drug development practices. As the leader of the Company, Dr. Siegall led to the development of antibody-drug conjugate (ADC) used in the therapy of cancer.
Dr. Clay B. Siegall holds a Bachelor of Science in Zoology from the University of Maryland, and he is also a holder of Ph.D. in genetics from the University of George Washington. Under Dr. Clay Siegall leadership, Seattle Genetics has emerged from a scratch to venturing into multiple strategic licenses for its ADC technology that consists of AbbVie, Genentech, Pfizer, and GlaxoSmithKline, which have generated revenue of more than $ 300 million. The Company grew from a crew of researchers to become one of the most successful cancer research space. The Company’s potential indications in the development of expanding the list of drugs are evident that Seattle Genetics with its existing drug portfolio is well-positioned to develop an industry with authority in the 21st Century.
Seattle Genetics’ technology has widely been embraced and has gained internal and collaborator programs that have given rise to more than 20 ADCs clinics. Through Seattle Genetics’ Dr. Siegall has managed to develop capital raising activities that have given rise to more than $ 675 million through private financings, public and company’s initial public in the year 2001. Dr. Siegall diminishes the fact that the old ways of treating cancer through systematic chemotherapies are no longer useful in the treatment of cancer. He firmly believes that the value and efficacy of the therapies developed will become more evident in the decades to come. He argues that the old treatments will soon be replaced by the development of more effective targeted drugs.